The role of complement in myasthenia gravis: Serological evidence of complement consumption in vivo

Journal of Neuroimmunology

Volumn 158, Issue 1-2, 2005, Pages 191-194

  Romi, Fredrik ^a   Kristoffersen, Einar K ^a   Aarli, Johan A ^a,b   Gilhus, Nils Erik ^a,b  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

Author keywords

Acetylcholine receptor antibodies; C3; C4; Complement activation; Myasthenia gravis; Ryanodine receptor antibodies; Titin antibodies

Indexed keywords

CHOLINERGIC RECEPTOR ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; RYANODINE RECEPTOR;

ARTICLE; COMPARATIVE STUDY; COMPLEMENT SYSTEM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYASTHENIA GRAVIS; PRIORITY JOURNAL; SEROLOGY;

ANTIBODIES; COMPLEMENT C3C; COMPLEMENT C4B; DISABILITY EVALUATION; FEMALE; HISTORY, ANCIENT; HUMANS; MALE; MUSCLE PROTEINS; MYASTHENIA GRAVIS; PEPTIDE FRAGMENTS; PROTEIN KINASES; RECEPTORS, CHOLINERGIC; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL;

EID: 10344264998     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2004.08.002     Document Type: Article

References (25)

1. J.A. Aarli, N.E. Gilhus, and H. Hofstad CA-antibody: an immunological marker of thymic neoplasia in myasthenia gravis? Acta Neurol. Scand. 63 1987 55 57
2. J.A. Aarli, K. Stefansson, L.S.G. Marton, and R.L. Wollmann Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin Clin. Exp. Immunol. 82 1990 284 288
3. A.G. Engel, and K. Arahata The membrane attack complex of complement at the endplate in myasthenia gravis Ann. N.Y. Acad. Sci. 505 1987 326 332
4. J.B. Kuks, P.C. Limburg, G. Horst, and H.J. Oosterhuis Antibodies to skeletal muscle in myasthenia gravis: Part 3. Relation with clinical course and therapy J. Neurol. Sci. 120 1993 168 173
5. A.K. Lefvert, K. Bergstrøm, G. Matell, P.O. Osterman, and R. Pirskanen Determination of acetylcholine receptor antibody in myasthenia gravis-clinical usefulness and pathogenic implications J. Neurol. Neurosurg. Psychiatry 41 1978 394 403
6. J. Lindström Immunobiology of myasthenia gravis, experimental autoimmune myasthenia gravis, and Lambert-Eaton syndrome Annu. Rev. Immunol. 3 1985 109 131
7. J.M. Lindström, M.E. Seybold, V.A. Lennon, S. Whittingham, and D.D. Duane Antibody to acetylcholine receptor in myasthenia gravis: prevalence, clinical correlates, and diagnostic value. 1975 Classical article Neurology 51 1998 933 939
8. J. McConville, M.E. Farrugia, D. Beeson, U. Kishore, R. Metcalfe, J. Newsom-Davis, and A. Vincent Detection and characterization of MuSK antibodies in seronegative myasthenia gravis Ann. Neurol. 55 2004 580 584
9. Å. Mygland, O.B. Tysnes, J.A. Aarli, P.R. Flood, and N.E. Gilhus Myasthenia gravis patients with a thymoma have antibodies against a high molecular weight protein in sarcoplasmatic reticulum J. Neuroimmunol. 37 1992 1 7
10. Å. Mygland, O.B. Tysnes, R. Matre, P. Volpe, J.A. Aarli, and N.E. Gilhus Ryanodine receptor autoantibodies in myasthenia gravis patients with thymoma Ann. Neurol. 32 1992 589 591
11. Å. Mygland, O.B. Tysnes, J.A. Aarli, R. Matre, and N.E. Gilhus IgG subclass distribution of ryanodine receptor autoantibodies in patients with myasthenia gravis and thymoma J. Autoimmun. 6 1993 507 515
12. Å. Mygland, J.A. Aarli, R. Matre, and N.E. Gilhus Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis J. Neurol. Neurosurg. Psychiatry 57 1994 843 846
13. W.L. Nastuk, O.J. Plescia, and K.E. Osserman Changes in serum complement activity in patients with myasthenia gravis Proc. Soc. Exp. Biol. Med. 105 1960 177 184
14. H.J.G.H. Oosterhuis, P.C. Limburg, and E. Hummel-Tappel Anti-acetylcholine receptor antibodies in myasthenia gravis: Part 2. Clinical and serological follow-up of individual patients J. Neurol. Sci. 58 1983 371 385
15. K. Osserman, and G. Genkins Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients Mt. Sinai J. Med. 38 1971 497 537
16. O.J. Plescia, J.M. Segovia, and A. Strampp An assessment of changes in the complement level of myasthenic sera Ann. N.Y. Acad. Sci. 135 1966 580 587
17. A. Rødgaard, F.C. Nielsen, R. Djurup, F. Somnier, and S. Gammeltoft Acetylcholine receptor antibody in myasthenia gravis: predominance of IgG subclass 1 and 3 Clin. Exp. Immunol. 67 1987 82 88
18. F. Romi, G.O. Skeie, J.A. Aarli, and N.E. Gilhus Muscle autoantibodies in subgroups of myasthenia gravis patients J. Neurol. 247 2000 369 375
19. F. Romi, G.O. Skeie, J.A. Aarli, and N.E. Gilhus The severity of myasthenia gravis correlates with the serum concentration of titin and ryanodine receptor antibodies Arch. Neurol. 57 2000 1596 1600
20. F. Romi, G.O. Skeie, C. Vedeler, J.A. Aarli, F. Zorzato, and N.E. Gilhus Complement activation by titin and ryanodine receptor autoantibodies in myasthenia gravis. A study of IgG subclasses and clinical correlations J. Neuroimmunol. 111 2000 169 176
21. G.O. Skeie, Å. Mygland, J.A. Aarli, and N.E. Gilhus Titin antibodies in patients with late onset myasthenia gravis: clinical correlations Autoimmunity 20 1995 99 104
22. G.O. Skeie, E. Bartoccioni, A. Evoli, J.A. Aarli, and N.E. Gilhus Ryanodine receptor antibodies are associated with severe myasthenia gravis Eur. J. Neurol. 3 1996 136 140
23. G.O. Skeie, A. Mygland, S. Treves, N.E. Gilhus, J.A. Aarli, and F. Zorzato Ryanodine receptor antibodies in myasthenia gravis: epitope mapping and effect on calcium release in vitro Muscle Nerve 27 2003 81 89
24. E. Tuzun, B.G. Scott, E. Goluszko, S. Higgs, and P. Christadoss Genetic evidence for involvement of classical complement pathway in induction of experimental autoimmune myasthenia gravis J. Immunol. 171 2003 3847 3854
25. R.D. Voltz, W.C. Albrich, A. Nägele, F. Schumm, M. Wick, A. Freiburg, M. Gautel, H.T. Thaler, J.A. Aarli, T. Kirchner, and R. Hohlfeld Paraneoplastic myasthenia gravis: detection of anti-MGT30 (titin) antibodies predicts thymic epithelial tumor Neurology 49 1997 1454 1457